Learn more about how non-opioid options used before, during, and after surgery helped these real-life doctors and patients achieve an enhanced recovery experience.
Lea, a college soccer player, shares her journey through ACL surgery and explains how a non-opioid pain management approach helped her get back on the field sooner.
Greg describes the pain he experienced due to his knee osteoarthritis and shares how he received an extended-release treatment to find relief.
Physician assistant, Jason Rand, discusses how he utilizes an extended-relief treatment option to manage pain in patients living with knee osteoarthritis.
Before undergoing a double knee replacement, Mary Lou received iovera° to help her manage the pain and recover quicker after surgery.
Paula describes her experience with knee pain and how she found relief with iovera° before and after total knee replacement surgery.
Physician assistant, Mattie Collier, explains how she incorporates a non‑opioid intervention applied in her office into her pain management approach to benefit patients undergoing knee surgery.
Caroline shares how the use of a non‑opioid cryoanalgesia treatment helped to provide immediate, long‑lasting pain relief before and after her total knee replacement procedures.
Dr. Mark Mighell, an orthopedic surgeon who specializes in the treatment of shoulder and elbow injuries, discusses his multimodal pain management approach, which includes a long-acting local anesthetic injected during surgery.
Lisa details how a minimally invasive approach to her hysterectomy, coupled with non-opioid pain management options, enhanced her recovery experience.
EXPAREL®Indication EXPAREL® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa, and an adductor canal block. Safety and efficacy have not been established in other nerve blocks.
Important Safety InformationEXPAREL should not be used in obstetrical paracervical block anesthesia. In studies in adults where EXPAREL was injected into a wound, the most common side effects were nausea, constipation, and vomiting. In studies in adults where EXPAREL was injected near a nerve, the most common side effects were nausea, fever, headache, and constipation. In the study where EXPAREL was given to children, the most common side effects were nausea, vomiting, constipation, low blood pressure, low number of red blood cells, muscle twitching, blurred vision, itching, and rapid heartbeat. EXPAREL can cause a temporary loss of feeling and/or loss of muscle movement. How much and how long the loss of feeling and/or muscle movement depends on where and how much of EXPAREL was injected and may last for up to 5 days. EXPAREL is not recommended to be used in patients younger than 6 years old for injection into the wound, for patients younger than 18 years old for injection near a nerve, and/or in pregnant women. Tell your health care provider if you or your child has liver disease, since this may affect how the active ingredient (bupivacaine) in EXPAREL is eliminated from the body.
EXPAREL should not be injected into the spine, joints, or veins. The active ingredient in EXPAREL can affect the nervous system and the cardiovascular system; may cause an allergic reaction; may cause damage if injected into the joints; and can cause a rare blood disorder.
Full Prescribing Information is available at www.EXPAREL.com/patient.
For more information, please visit www.EXPAREL.com/patient or call 1-855-793-9727. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
ioveraºIndication ioveraº applies freezing cold to peripheral nerve tissue to block and/or relieve pain for up to 90 days. It should not be used to treat central nervous system tissue.
Important Safety Information
- Do not receive treatment with ioveraº if you experience hypersensitivity to cold or have open and/or infected wounds near the treatment site.
- You may experience bruising, swelling, inflammation and/or redness, local pain and/or tenderness, and altered feeling at the site of application.
- In treatment area(s), you may experience damage to the skin, skin darkening or lightening, and dimples in the skin.
- You may experience a temporary loss of your ability to use your muscles normally outside of the treatment area.
- Talk to your doctor before receiving treatment with ioveraº.
For full Indication and Important Safety Information, please see: www.iovera.com/risks
ZILRETTA®Indication ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) is an extended-release corticosteroid approved to manage osteoarthritis knee pain. The benefits and risks of repeat injections have not been demonstrated.
Who should not receive ZILRETTA?You should not receive a ZILRETTA injection if you are allergic to corticosteroids, triamcinolone acetonide, or any other component of the product.
IMPORTANT SAFETY INFORMATION
What possible side effects of corticosteroids could occur with ZILRETTA?
- Rare serious allergic reactions
- Effects in the injected knee such as infection (with pain, swelling and restricted motion) or joint damage
- Increased chance of getting an infection, and a decreased ability to fight an infection
- Effects on hormone production. These effects can be reversible
- Elevated blood pressure, sodium and water retention, and potassium loss
- Intestinal perforation if you have certain gastrointestinal disorders
- Weakening of bones
- Changes in behavior or mood disturbances
- Increased pressure inside the eye
What are the most common side effects of receiving a ZILRETTA injection?In multiple clinical trials, the most common side effects seen in people taking ZILRETTA were joint pain, headache, joint swelling, back pain, sore throat and runny nose, upper respiratory tract infection, and bruising.
What should you tell your doctor BEFORE receiving a ZILRETTA injection?Tell your doctor about all of the medications you are taking (including both prescription and over-the-counter medicines) and about any medical conditions, especially if you have high blood pressure, heart disease, ulcers, diverticulitis or other gastrointestinal disorders, kidney problems, diabetes, glaucoma, behavior or mood disorders, and/or infections.
What should you tell your doctor AFTER receiving a ZILRETTA injection?Contact your doctor if you develop a fever or other signs of infection, have an increase in pain along with swelling of the injected knee, restriction of joint motion, or a general feeling of discomfort. Contact your doctor immediately if you are exposed to chicken pox or measles, or for any new or worsening changes in behavior or mood.
These are not all of the possible side effects with ZILRETTA or corticosteroid medications. Please see the full Prescribing Information at www.ZILRETTALabel.com/PI.pdf. Always contact your doctor if you have questions or experience any side effects.
For more information, please visit www.zilrettapro.com or call 1-855-793-9727. You are encouraged to report negative side effects of prescription drugs to FDA; visit www.fda.gov/medwatch or call 1-800-FDA-1088.